What key drivers are advancing the diabetes care devices and sports medicine industries?

The diabetes care devices industry is witnessing strong growth driven by increasing diabetes prevalence. Intense competition between established firms and startups is fostering innovation, especially in artificial intelligence (AI)-powered technology. This advancement is broadening coverage from type 1 diabetes (T1D) to encompass type 2 diabetes (T2D) and prediabetes. Companies are implementing strategies to ensure consistent revenue and lower patient expenses. The industry is segmented into glucose monitoring (self-monitoring of blood glucose and continuous glucose monitoring systems) and insulin delivery (pumps and pens), with regional trends offering strategic avenues for growth.

The sports medicine industry is experiencing robust growth fuelled by innovative devices and emerging megatrends. Significant advancements in body reconstruction and support devices are at the forefront of this expansion. Companies are reshaping their business models to address current challenges, emphasizing athlete wellbeing, personalized care, and technology-driven injury prevention. Technologies such as 3D printed implants and generative AI are revolutionizing recovery methods and commercial strategies.